Cryo-Cell grants director Berger 5,300 stock options

The options vest at a rate of 1/12 per month beginning October 27, 2026, and expire October 27, 2036.

Rhea-AI Filing Summary

Cryo-Cell International Inc. director Harold D. Berger received a grant of 5,300 stock options on October 27, 2026, with a $4.96 per-share exercise price and an expiration date of October 27, 2036. The options vest at a rate of 1/12 per month commencing on October 27, 2026. The filing also lists 57,901 directly held common shares and an existing option covering 7,500 common shares at a $7.53 exercise price, expiring August 30, 2029.

Insider Trade Summary

Grant/Award: 5,300 shares

Grant/Award 10 txns

Insider Berger Harold D.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option F1	5,300	$4.96	$26K
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Options	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option — 44,600 contracts for 39,300 underlying shares (Direct); Stock Options — 5,300 contracts (Direct); Common Stock — 57,901 shares (Direct)

Footnotes (1)

1. F1. Stock options vest at a rate of 1/12 per month commencing on 10/27/2026.

Key Figures

Stock options granted: 5,300 options Exercise price: $4.96 per share Vesting rate: 1/12 per month +3 more

6 metrics

Stock options granted 5,300 options Grant dated October 27, 2026

Exercise price $4.96 per share Granted stock options

Vesting rate 1/12 per month Commencing October 27, 2026

Expiration date October 27, 2036 Granted stock options

Direct common shares held 57,901 shares Direct holding

Existing option underlying shares 7,500 shares $7.53 exercise price; expires August 30, 2029

Key Terms

stock option, vest, exercise price

3 terms

stock option financial

"grant of 5,300 stock options"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

vest financial

"Stock options vest at a rate of 1/12 per month"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

exercise price financial

"stock options with a $4.96 exercise price"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many stock options did CCEL director Harold D. Berger receive?

Harold D. Berger received 5,300 stock options on October 27, 2026, at a $4.96 per-share exercise price. They vest at a rate of 1/12 per month commencing on October 27, 2026, and expire October 27, 2036.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/28/2026 - 05:00 PM EDT Accepted by SEC EDGAR 10/28/2026 - 05:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Berger Harold D.

(Last) (First) (Middle)

700 BROOKER CREEK BLVD

SUITE 1800

(Street)

OLDSMAR FLORIDA 34677

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CRYO CELL INTERNATIONAL INC [ CCEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								57,901	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$7.53							08/30/2019	08/30/2029	Common Stock	7,500		7,500	D
Stock Option	$7.74							11/25/2019	11/25/2029	Common Stock	5,300		5,300	D
Stock Option	$7.85							09/22/2020	09/22/2030	Common Stock	5,300		5,300	D
Stock Option	$12.63							10/20/2021	10/20/2031	Common Stock	5,300		5,300	D
Stock Option	$6.5							10/03/2022	10/03/2032	Common Stock	5,300		5,300	D
Stock Option	$4.9							10/10/2023	10/10/2033	Common Stock	5,300		5,300	D
Stock Option	$5.82							10/29/2024	10/29/2034	Common Stock	5,300		5,300	D
Stock Options	$4.35							10/21/2025	10/21/2035	Common Stock	5,300		5,300	D
Stock Option	$4.96	10/27/2026		A		5,300		10/27/2026(1)	10/27/2036	Common Stock	5,300	$4.96	5,300	D

Explanation of Responses:

1. Stock options vest at a rate of 1/12 per month commencing on 10/27/2026.

	/s/ Harold Berger	10/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)